Roger Wilson on the challenges of being a cancer survivor
1 Feb 2018
Roger Wilson was diagnosed with a soft tissue sarcoma in 1999. Roger has had ten operations, chemotherapy and radiotherapy. These have included a lower leg amputation in 2007 and two thoracic metastectomy operations in mid-2013. Three years after his diagnosis, Roger started work on what has become Sarcoma UK. Initially, it acted as a hub of information but with an increasing number of patients and carers becoming involved, it grew to provide a wider range of services. His experience as a cancer survivor is a significant testimonial to define the challenges faced by cancer survivors.
“Being a cancer survivor can feel lonely. As far as everyone else is concerned you look normal (except in my case, because I have had an amputation) but you have this experience behind you which is hard to forget and can shape the way you react to situations. Possibly the biggest challenge is psychological.” said Roger.
Over the past several decades, tremendous progress has been achieved on the survival of cancer patients thanks to successful clinical research and innovative drugs. Today, a cancer diagnosis is no longer a death sentence. “However, we lack research into survivorship,” said Roger “and what there has been is very fragmented, so having a strategically driven event such as EORTC Cancer Survivorship Summit which allows people to come together to consider how we set research agendas in survivorship is badly needed.”
Willing to answer this issue, the EORTC created the Survivorship Summit to bring together multidisciplinary experts that will address physical and psychological issues but also the societal issues so the survivors can get back to normal life, which includes obtaining financial services and health insurances.
“As someone who was treated on an EORTC clinical trial in 2000 (EORTC 62971) I have always been aware of the organisation and of the breadth of its work. As a rare cancer patient working nationally in research I have also been aware how EORTC has supported research into my particular tumour type,” said Roger Wilson. “More recently I have been involved in work on quality-of-life and here EORTC has been a leader internationally. So I applaud EORTC, I enjoy working with its team of many talents.”
Roger Wilson is the Chair of the Physical issues session, where he will talk about the patient’s perspective, during in the 3rd EORTC Survivorship Summit which will take place in Brussels Belgium, 1- 2 March 2018.
Related News
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
11 Dec 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
21 Nov 2024
IMMUcan has completed patient enrolment
12 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
5 Nov 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
29 Oct 2024
Spotlight on ENA 2024 News
25 Oct 2024
Do regulations and policies undermine the social value of independent academic research?
25 Oct 2024
EORTC Quality of Life Group’s participation to ISOQOL 2024
10 Oct 2024
New Insights into Glioblastoma Treatment for Older Adults Patients
8 Oct 2024
TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival
24 Sep 2024